CAMBRIDGE, Massachusetts and HEIDELBERG, Germany, May 9, 2015 /PRNewswire/ --
Molecular Health today announced it has won an SAP HANA® Innovation Award in the category Technology Trailblazer - Business Application. The awards presented by SAP SE (NYSE: SAP) recognize the extraordinary ways that customers are using the SAP HANA platform to transform their business and society. Molecular Health received its award at a ceremony hosted by SAP at SAPPHIRE® NOW and the ASUG Annual Conference held May 5-7 in Orlando, Fla.
Dr. Marco Lenck, Chairman of the SAP Users' Group in Germany (DSAG) lauded Molecular Health at the awards ceremony, saying, "Molecular Health is using SAP HANA in a way that is most helpful for people, helping deliver personalized treatment for cancer treatment that can save so many lives."
The SAP HANA Innovation Award received nearly 50 submissions from over 30 countries. Winners were chosen in six categories, recognizing and celebrating customers that have deployed both packaged and custom applications on SAP HANA to enable real-time analytics, process simplification and technology innovations. More than 18,000 public votes were cast to determine the top finalists in each of the six categories. The finalists were judged by an expert panel comprised of SAP executives, SAP users' groups, product experts and industry analysts. Molecular Health was chosen as the winner of the Technology Trailblazer - Business Application, for its TreatmentMAP solution.
Accepting the award for Molecular Health, CEO Lutz Voelker said, "It is an honor for Molecular Health to be recognized with an SAP HANA Innovation Award, as a company that has the right product at the right time for the right market. We are grateful to be selected for this award and we are pleased to be using SAP HANA as a powerful and scalable platform to support our global rollout."
At the awards ceremony, Molecular Health's CEO Lutz Voelker and Executive Vice President of Marketing and Product Management Dr. Alexander Picker demonstrated Molecular Health's TreatmentMAP. They showed how the solution uses SAP HANA to transform complex and large data sets on individualized genetic information from a cancer patient using all published biomedical knowledge to identify the treatment options that are most promising to deliver favorable outcomes. During the demonstration, Dr. Picker used an actual example of a lung-cancer patient for whom TreatmentMAP discovered that the most common courses of treatment would not have been effective. TreatmentMAP also identified a new drug that would be effective and a suitable clinical study. Six months later, this patient is still receiving effective treatment from this medication and is not suffering from any serious side effects. This is but one of many examples in which Molecular Health's TreatmentMAP is used by physicians to make data-driven, evidence-based treatment decisions for cancer patients.
SAP is the first company to use Molecular Health's Corporate Oncology Program for Employees (COPE), which provides Molecular Health's TreatmentMAP at no cost to its employees in the U.S. and Germany who get diagnosed with cancer.
SAP HANA combines database, data processing, and application platform capabilities in-memory. The platform provides libraries for predictive, planning, text processing, spatial and business analytics. By providing advanced capabilities, such as predictive text analytics, spatial processing and data virtualization on the same architecture, it further simplifies application development and processing across big-data sources and structures. This makes SAP HANA a highly suitable platform for building and deploying next-generation, real-time applications and analytics.
SAPPHIRE NOW and the ASUG Annual Conference are the world's premier business technology event and largest SAP customer-run conference, offering attendees the opportunity to learn and network with customers, SAP executives, partners and experts across the entire SAP ecosystem.
About MOLECULAR HEALTH
Molecular Health is a leading biomedical company that is transforming molecular data and medical knowledge into actionable clinical information for more efficient and safe cancer treatment options for each individual cancer patient. Molecular Health's TreatmentMAP is the first registered medical device of its kind for the personalized cancer medicine in Europe. Molecular Health GmbH is audited and certified per DIN EN ISO 13485 for the design, development and production of software systems for the integrated analysis of clinical and genomic patient data to support treatment decisions and provision of related services. Learn more: http://www.molecularhealth.com
SAP, SAP HANA, SAPPHIRE and other SAP products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of SAP SE (or an SAP affiliate company) in Germany and other countries. See http://www.sap.com/corporate-en/legal/copyright/index.epx for additional trademark information and notices.
All other product and service names mentioned are the trademarks of their respective companies.
Molecular Health Press Contacts
North America: Mark Rodgers: +1-832-247-3068 mark.rodgers@molecularhealth.com
Europe / ROW: Rudi Schmidt: +491716050043 media@molecularhealth.com
